Document Detail


Calcium antagonists in secondary prevention after acute myocardial infarction: the Secondary Prevention Reinfarction Nifedipine Trial (SPRINT).
MedLine Citation:
PMID:  3530769     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
SPRINT was a double-blind, randomized placebo controlled multi-centre trial based in Israel, designed to test whether nifedipine 10 mg X 3 daily would reduce morbidity and mortality during 1 year follow-up in 2279 male and female survivors of acute myocardial infarction. 335 patients were adjudged to be trial deviations. 130 (5.7%) of patients died and 105 (4.6%) experienced a non-fatal myocardial reinfarction. Analysis of the results by trial medication is awaited.
Authors:
H N Neufeld
Related Documents :
392079 - A randomized controlled trial of aspirin in the prevention of early mortality in myocar...
17696569 - Incremental effect of clopidogrel on important outcomes in patients with cardiovascular...
19738549 - Prasugrel (effient) vs. clopidogrel (plavix).
8043909 - Thrombinogenesis and its pharmacological modulation in atherosclerosis.
15448779 - Treating heparin-induced thrombocytopenia. the unconventional way!
18220489 - Antiplatelet therapy with clopidogrel and aspirin in vascular diseases: clinical eviden...
11862579 - Circulating levels of interleukin 18 reflect etiologies of heart failure: th1/th2 cytok...
7260699 - Preservation of fowl semen in liquid nitrogen: application to breeding programmes.
10692089 - Silent cerebral infarction: a potential risk for pneumonia in the elderly.
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  European heart journal     Volume:  7 Suppl B     ISSN:  0195-668X     ISO Abbreviation:  Eur. Heart J.     Publication Date:  1986 Jul 
Date Detail:
Created Date:  1986-11-07     Completed Date:  1986-11-07     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  8006263     Medline TA:  Eur Heart J     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  51-2     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Clinical Trials as Topic
Double-Blind Method
Female
Humans
Male
Myocardial Infarction / drug therapy*
Nifedipine / therapeutic use*
Chemical
Reg. No./Substance:
21829-25-4/Nifedipine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Withdrawal of long-term amrinone therapy in patients with congestive heart failure: a placebo contro...
Next Document:  90-minute 99mTc-MDP scintigraphy and 131I-hippuran renography in recently allotransplanted kidneys: ...